These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1003711)

  • 21. The cardiovascular and autonomic properties of N-phenylpiperazine (NPP) in several animal models.
    Cohen MR; Hinsch E; Palkoski Z; Vergona R; Urbano S; Sztokalo J
    J Pharmacol Exp Ther; 1982 Oct; 223(1):110-9. PubMed ID: 6126578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular actions of 2,5-dimethoxy-4-methylamphetamine (DOM) in the cat.
    Tadepalli AS; Friedman E; Gershon S
    Eur J Pharmacol; 1975 Apr; 31(2):305-12. PubMed ID: 1056857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of guanabenz on the cardiovascular system, in comparison with clonidine and guanethidine].
    Hojo M; Yoshida Y; Nagasaka Y; Machida K; Tatsumi H
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):39-58. PubMed ID: 6852681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of nicotine on spontaneous contractions of cat urinary bladder in situ.
    Koley B; Koley J; Saha JK
    Br J Pharmacol; 1984 Oct; 83(2):347-55. PubMed ID: 6487900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).
    Scholtysik G; Lauener H; Eichenberger E; Bürki H; Salzmann R; Müller-Schweinitzer E; Waite R
    Arzneimittelforschung; 1975 Oct; 25(10):1483-91. PubMed ID: 1243025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analysis of the peripheral effects of l-DOPA on autonomic nerve function.
    Antonaccio MJ; Robson RD
    Br J Pharmacol; 1974 Sep; 52(1):41-50. PubMed ID: 4451808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of the cardiovascular activity of dibenzoxazepine in cats.
    Lundy PM
    Eur J Pharmacol; 1978 Apr; 48(3):271-9. PubMed ID: 639855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
    Arisawa H; Fukui K; Fujise N; Masunaga H
    Arzneimittelforschung; 2002; 52(2):81-8. PubMed ID: 11878203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reserpine-resistant responses to nerve stimulation in the cat nictitating membrane involve the release of newly synthesized noradrenaline.
    Duval N; Hicks PE; Langer SZ
    Eur J Pharmacol; 1986 Mar; 122(1):93-101. PubMed ID: 2869963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
    Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines.
    Buschmann G; Kühl UG; Rohte O
    Arzneimittelforschung; 1985; 35(11):1643-55. PubMed ID: 2868732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RA 642, a pyrimido-pyrimidine-derivative with vasodilating and hypertensive potency.
    Kadatz R; Kobinger W; Walland A
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):97-103. PubMed ID: 940597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059.
    Pittner H; Stormann H; Enzenhofer R
    Arzneimittelforschung; 1976; 26(12):2145-54. PubMed ID: 66056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological analysis of the mode of action of mandelamidine with sustained antihypertensive effect. (II). Mechanism of transient hypotensive action of mandelamidine].
    Ozawa H; Hironaka Y
    Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):559-71. PubMed ID: 1238327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [General pharmacology of aclacinomycin A (author's transl)].
    Ohmori K; Hirano S; Hori S
    Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supersensitivity of the nictitating membrane to 5-hydroxytryptamine and norepinephrine after various procedures.
    Wakade AR; Kanwar RS; Gulati OD
    J Pharmacol Exp Ther; 1970 Oct; 175(1):189-96. PubMed ID: 5471446
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacological effects of [(octahydro-2-azocinyl)methyl] guanidine(guanazodine): its action mechanism and hypotensive effect].
    Shimizu T; Hamakawa H; Tozuka T; Ono H
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):837-50. PubMed ID: 1035187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some direct and indirect sympathomimetic actions of metaraminol.
    Stone CA; Stavorski JM; Ludden CT; Wenger HC; Torchiana ML
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):49-60. PubMed ID: 5941882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.